IN2014MU01326A - - Google Patents

Info

Publication number
IN2014MU01326A
IN2014MU01326A IN1326MU2014A IN2014MU01326A IN 2014MU01326 A IN2014MU01326 A IN 2014MU01326A IN 1326MU2014 A IN1326MU2014 A IN 1326MU2014A IN 2014MU01326 A IN2014MU01326 A IN 2014MU01326A
Authority
IN
India
Prior art keywords
aceclofenac
acryloyl
stable
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
Other languages
English (en)
Inventor
Gour Mukherji
Vijayendrakumar Virendrakumarji Redasani
Prutha Shrikrishna Gaitonde
Vaibhavi Ankur Shah
Original Assignee
Inventia Healthcare Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inventia Healthcare Private Ltd filed Critical Inventia Healthcare Private Ltd
Priority to IN1326MU2014 priority Critical patent/IN2014MU01326A/en
Publication of IN2014MU01326A publication Critical patent/IN2014MU01326A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN1326MU2014 2014-04-10 2014-04-10 IN2014MU01326A (OSRAM)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN1326MU2014 IN2014MU01326A (OSRAM) 2014-04-10 2014-04-10

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1326MU2014 IN2014MU01326A (OSRAM) 2014-04-10 2014-04-10

Publications (1)

Publication Number Publication Date
IN2014MU01326A true IN2014MU01326A (OSRAM) 2015-10-16

Family

ID=54395754

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1326MU2014 IN2014MU01326A (OSRAM) 2014-04-10 2014-04-10

Country Status (1)

Country Link
IN (1) IN2014MU01326A (OSRAM)

Similar Documents

Publication Publication Date Title
NO2022059I1 (no) Lenacapavir or a pharmaceutically acceptable salt thereof, in particular lenacapavir sodium
NO2025022I1 (no) Belzutifan, or a pharmaceutically acceptable salt thereof, particularly belzutifan.
NL301260I2 (nl) Gefapixant, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout.
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
EP3154594A4 (en) Fap-activated therapeutic agents, and uses related thereto
EP3353305A4 (en) Conjugated antisense compounds and their use
EP3249382A4 (en) Biological-specimen transparentizing agent, system, and use therefor
EP3068442A4 (en) Bionanofluid for use as a contrast, imaging, disinfecting and/or therapeutic agent
EP3102193A4 (en) Antibacterial agents: n(alpha)-aroyl-n-aryl-phenylalaninamides
PH12017501084A1 (en) Insulin glargine/lixisenatide fixed ratio formulation
EP3239210A4 (en) Active energy ray-curable composition, and use thereof
PL3232780T3 (pl) Kompozycje adiuwantowe zawierające wodny elektrolit, kompozycje zawierające składnik czynny i ich zastosowanie
MX366499B (es) Composicion farmaceutica liquida.
EP3583934A4 (en) BIOCID
EP3168305A4 (en) Antisense antineoplastic agent
SI3226905T1 (sl) Konjugati hialuronana s farmacevtskimi učinkovinami, postopki in sestavki
EP3223817A4 (en) Substantially pure vemurafenib and its salts
EP3095453A4 (en) Topical agent for transdermal administration
FR3024733B1 (fr) Agent epaississant pour systemes aqueux, formulations le contenant et utilisations.
EP3025733A4 (en) Pharmaceutical, water-soluble and antifungal macromolecular compound
GB2543709A (en) Pharmaceutical agent
PH12018500579A1 (en) Fungal keratitis prophylactic or therapeutic agent
PL3253857T3 (pl) Preparaty wodne, ich wytwarzanie i zastosowanie
EP3048886A4 (en) 3, 4-bis-benzylsulfonylbutanenitrile and its pharmaceutical use